Newspaper publication of addendum to public announcement
ZYDUSLIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Zydus Lifesciences has issued an addendum to its earlier buyback announcement, published on May 28, 2026 in major newspapers. The key change is an increase in the buyback price from INR 1,150 to INR 1,260 per equity share, representing a 9.6% increase. Consequently, the maximum number of shares to be bought back has been reduced from 95,65,217 shares to 87,30,158 shares. The buyback continues to represent up to 0.87% of the company's total paid-up share capital. The addendum is published in English (Financial Express), Hindi (Jansatta), and Gujarati (Financial Express - Ahmedabad edition). The buyback is being conducted through the tender offer route under SEBI Buy-Back Regulations, 2018.
The increased buyback price signals that the company is willing to pay a premium to acquire its shares, which is positive for shareholders as they can now sell at a higher price. The higher price (INR 1,260) may also indicate management's view that the current market price undervalues the stock. Shareholders interested in tendering their shares will benefit from the enhanced offer.